Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil, Cyclophosphamide, and Trastuzumab in Metastatic Breast Cancer
NCT00331552Phase 2Completed
- Sponsor
- University of Washington
- Start
- Feb 2006
- Primary completion
- Feb 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by University of Washington. Started Feb 2006; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00331552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331552.